Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Lancet Infect Dis. 2022 Jun;22(6):765-766. doi: 10.1016/S1473-3099(22)00283-3.

Authors

Rob W van der Pluijm¹, Thomas J Peto¹, Mainga Hamaluba², James J Callery¹, Rupam Tripura¹, Nicholas J White¹, Arjen M Dondorp³

Affiliations

¹ Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.
² KEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
³ Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand. Electronic address: arjen@tropmedres.ac.

No abstract available

Publication types

Letter
Comment

MeSH terms

Artemisinins* / therapeutic use
Humans
Malaria* / drug therapy

Substances

Artemisinins

Grants and funding

203077/WT_/Wellcome Trust/United Kingdom